Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
CGC 
Canopy Growth Corp (CGC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/13/2025: CGC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -48.89% | Avg. Invested days 16 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/13/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 275.69M USD | Price to earnings Ratio - | 1Y Target Price 2.31 |
Price to earnings Ratio - | 1Y Target Price 2.31 | ||
Volume (30-day avg) 8196404 | Beta 2.14 | 52 Weeks Range 0.77 - 8.65 | Updated Date 06/19/2025 |
52 Weeks Range 0.77 - 8.65 | Updated Date 06/19/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -4.14 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-05-30 | When - | Estimate -0.205 | Actual -1.3232 |
Profitability
Profit Margin -222.35% | Operating Margin (TTM) -6.09% |
Management Effectiveness
Return on Assets (TTM) -3.63% | Return on Equity (TTM) -122.33% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 400247711 | Price to Sales(TTM) 1.02 |
Enterprise Value 400247711 | Price to Sales(TTM) 1.02 | ||
Enterprise Value to Revenue 2.04 | Enterprise Value to EBITDA -1.06 | Shares Outstanding 186892000 | Shares Floating 185119985 |
Shares Outstanding 186892000 | Shares Floating 185119985 | ||
Percent Insiders 0.95 | Percent Institutions 8.27 |
Analyst Ratings
Rating 2.5 | Target Price 2.28 | Buy 2 | Strong Buy - |
Buy 2 | Strong Buy - | ||
Hold 4 | Sell 1 | Strong Sell 3 | |
Strong Sell 3 |
Upturn AI SWOT
Canopy Growth Corp
Company Overview
History and Background
Canopy Growth Corp was founded in 2013 and is headquartered in Smiths Falls, Ontario. Initially known as Tweed Marijuana Inc., it was one of the first publicly traded cannabis companies in Canada. Canopy Growth has since expanded globally through acquisitions and partnerships.
Core Business Areas
- Cannabis Production: Cultivation, processing, and sale of dried cannabis flower, oils, concentrates, and edibles.
- Beverages: Development and distribution of cannabis-infused beverages.
- Vaporizers: Sale of cannabis vaporizers and related products.
- International Expansion: Expanding product line into multiple international markets, where cannabis is legal.
Leadership and Structure
David Klein is the Chief Executive Officer. The company has a board of directors overseeing strategic direction and governance.
Top Products and Market Share
Key Offerings
- Dried Flower: Various strains of dried cannabis flower for recreational and medical use. Market share fluctuates but remains a significant revenue driver. Competitors include Aurora Cannabis, Tilray, and Organigram.
- market_share: 12
- Cannabis Oils: Cannabis extracts for oral consumption. The market is competitive with increasing numbers of cannabis oils products available. Competitors include Aurora Cannabis, Cronos Group, and Aphria.
- market_share: 8
- Cannabis Beverages: CBD-infused beverages sold under various brands. The cannabis beverage market is still nascent but growing. Competitors include Truss Beverage Co and Keef Brands.
- market_share: 5
- Vaporizers: Cannabis vaporizers. Competition stems from brands such as PAX Labs and G Pen.
- market_share: 4
Market Dynamics
Industry Overview
The cannabis industry is experiencing rapid growth but also facing regulatory uncertainties, intense competition, and evolving consumer preferences.
Positioning
Canopy Growth is one of the largest cannabis companies globally, aiming to be a leader in the space. It focuses on brand building, product innovation, and strategic partnerships to gain a competitive edge.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions of dollars in the coming years. Canopy Growth is positioned to capture a significant portion of this TAM, but faces strong competition and regulatory hurdles.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Extensive distribution network
- Significant production capacity
- Early mover advantage
- Focus on innovation
Weaknesses
- High operating costs
- Inconsistent profitability
- Inventory write-downs
- Dependence on regulatory approvals
- Dilution from equity financing
Opportunities
- Expansion into new markets
- Development of innovative products
- Increased legalization and acceptance of cannabis
- Partnerships with established consumer brands
- Growth in medical cannabis sector
Threats
- Intense competition
- Regulatory uncertainty
- Price volatility
- Supply chain disruptions
- Changing consumer preferences
Competitors and Market Share
Key Competitors
- ACB
- TLRY
- OGI
Competitive Landscape
Canopy Growth faces intense competition from other cannabis companies, both large and small. The company's strengths include its brand recognition and distribution network, while its weaknesses include high costs and inconsistent profitability.
Major Acquisitions
Supreme Cannabis
- Year: 2021
- Acquisition Price (USD millions): 346
- Strategic Rationale: Expanded Canopy's brand portfolio and production capacity.
Growth Trajectory and Initiatives
Historical Growth: Canopy Growth experienced rapid growth in its early years, driven by increasing cannabis legalization. Growth has slowed in recent years amid challenges in the cannabis market.
Future Projections: Future growth projections are uncertain, depending on the success of cost-cutting initiatives, market expansion, and new product launches. Analyst estimates vary widely.
Recent Initiatives: Recent initiatives include cost reduction programs, streamlining operations, focusing on key markets, and developing new cannabis-infused products.
Summary
Canopy Growth Corp. is a major player in the cannabis industry, but struggles with profitability and faces intense competition. Its strong brand and distribution network are assets, but high costs and regulatory hurdles are challenges. Successful cost reduction and market expansion are critical for future success. The company needs to carefully watch how their balance sheet is trending, as well as how they are performing compared to their competitors.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Financial News Outlets
Disclaimers:
The information provided is for informational purposes only and should not be construed as financial advice. Market share data is approximate and subject to change. Financial data should be verified with official sources.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Canopy Growth Corp
Exchange NASDAQ | Headquaters Smiths Falls, ON, Canada | ||
IPO Launch date 2014-04-04 | CEO & Director Mr. Luc Mongeau | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 960 | Website https://www.canopygrowth.com |
Full time employees 960 | Website https://www.canopygrowth.com | ||
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.